LAB
Standard Biotools Inc.
A maker of scientific instruments used by biomedical researchers to study individual cells and proteins. Its three platforms—CyTOF mass cytometry, Hyperion spatial proteomics, and Biomark genomics—are sold to academic labs, translational centers, and biopharma companies. Founded in 1999 as Mycometrix and renamed Fluidigm in 2001 (a play on the "fluid" microchips it builds), the company became Standard BioTools in 2022, after its microfluidics "integrated fluidic circuits" were born from a Caltech lab that manipulates fluids on chips much like electronics handle electrons.
CUSIP: 34385P108HealthcareUS2 holders
Total Value
$58.21M
Total Shares
61.71M
Net Share Change
-18.3K
Activity
1 selling
Investor
Value
Shares
Weight
Change
